NeuClone is a clinical stage biopharmaceutical company exclusively developing and commercialising high quality biosimilar products. Led by a team of industry veterans, we are focused on creating a deep pipeline of high quality biosimilars at the scale and price to meet demand in both new and established markets globally. NeuClone is differentiated by our deep and unmatched pipeline, as well as our Right From the Start® approach where we continually confirm biosimilarity at the earliest stages and throughout development.
Company Details
- Employees
- 9
- Address
- 4 Cornwallis St, Sydney,new South Wales,australia
- Phone
- 61292094020
- in****@****one.com
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- http://neuclone.com
- Keywords
- biosimilars, monoclonal antibodies, biosimilar antibody development in CHO cells, therapeutic antibodies, biologics.
- HQ
- Sydney, New South Wales
Neuclone Questions
Neuclone's helpline number is 61292094020
Neuclone's website is http://neuclone.com
Neuclone's LinkedIn profile is https://au.linkedin.com/company/neuclone-pty-ltd
Neuclone has
9 employees.
View email and phone details for 9
employees at Neuclone.
Neuclone's industry is
Pharmaceutical Manufacturing
Neuclone's top competitors are
Biofoundry,
Actinogen Medical,
Novotech,
Bioinnovatiq Lifescience Pvt. Ltd.,
Bell Potter Securities,
Xbrane Biopharma Ab,
Incannex Healthcare Inc,
Formycon Ag,
Anthrocell Pty Ltd,
Blue Moon Life Sciences Pty Ltd.
Neuclone's support email address is info@neuclone.com
Neuclone's categories are Pharmaceutical Manufacturing
